Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: rocket who wrote (14135)	2/3/1998 4:34:00 PM
From: Henry Niman	Respond to of 32384

Karl, The street has been a bit slow on the pickup, but the pharmas will feel the pressure to develop the blockbuster drugs which will do wonders for LGND's pipeline. They are grossly underfunded, and the big boys should be anxious to wheel and deal or quickly develop compounds. The number of INDs for LGND's partners will surely be a record and the street will figure things out sooner of later. LGND's partners plan 6 INDs this year and 5 of them target Billion dollar markets and two compounds in the clinic will also advance and they also target Billion dollar markets.